Additionally, studies by Sadoughi [97] and Haeri et al. [98] indicated that CR alleviates inflammation in AD by targeting multiple pathways, such as reducing pro-inflammatory cytokines like TNF-α and IL-1β. The gene discussed is IL1B; the disease is Alzheimer disease.